Cannabinoids and the expanded endocannabinoid system in neurological disorders

L Cristino, T Bisogno, V Di Marzo - Nature Reviews Neurology, 2020 - nature.com
Anecdotal evidence that cannabis preparations have medical benefits together with the
discovery of the psychotropic plant cannabinoid Δ9-tetrahydrocannabinol (THC) initiated …

From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology

A Ligresti, L De Petrocellis… - Physiological …, 2016 - journals.physiology.org
Apart from having been used and misused for at least four millennia for, among others,
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli

K Maresz, EJ Carrier, ED Ponomarev… - Journal of …, 2005 - Wiley Online Library
The cannabinoid system is known to be important in neuronal regulation, but is also capable
of modulating immune function. Although the CNS resident microglial cells have been …

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells

E Eljaschewitsch, A Witting, C Mawrin, T Lee… - Neuron, 2006 - cell.com
Endocannabinoids are released after brain injury and believed to attenuate neuronal
damage by binding to CB 1 receptors and protecting against excitotoxicity. Such excitotoxic …

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand

T Sugiura, S Kishimoto, S Oka, M Gokoh - Progress in lipid research, 2006 - Elsevier
2-Arachidonoylglycerol (2-AG) is a unique molecular species of monoacylglycerol isolated
in 1995 from rat brain and canine gut as an endogenous ligand for the cannabinoid …

[HTML][HTML] The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases

V Chiurchiù, M van der Stelt, D Centonze… - Progress in …, 2018 - Elsevier
Multiple sclerosis is the most common inflammatory demyelinating disease of the central
nervous system, caused by an autoimmune response against myelin that eventually leads to …

Intracellular molecular targets and signaling pathways involved in antioxidative and neuroprotective effects of cannabinoids in neurodegenerative conditions

A Tadijan, I Vlašić, J Vlainić, D Đikić, N Oršolić… - Antioxidants, 2022 - mdpi.com
In the last few decades, endocannabinoids, plant-derived cannabinoids and synthetic
cannabinoids have received growing interest as treatment options in neurodegenerative …

Endocannabinoid signaling in microglial cells

N Stella - Neuropharmacology, 2009 - Elsevier
The endocannabinoid signaling system (eCBSS) is composed of cannabinoid (CB)
receptors, their endogenous ligands (the endocannabinoids, eCB) and the enzymes that …

Endocannabinoids and the regulation of their levels in health and disease

V Di Marzo, S Petrosino - Current opinion in lipidology, 2007 - journals.lww.com
Endocannabinoid levels appear to be transiently elevated as an adaptive reaction to re-
establish normal homeostasis when this is acutely and pathologically perturbed. In some …

Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine

I Agrawal, YS Lim, SY Ng, SC Ling - Translational Neurodegeneration, 2022 - Springer
Lipids, defined by low solubility in water and high solubility in nonpolar solvents, can be
classified into fatty acids, glycerolipids, glycerophospholipids, sphingolipids, and sterols …